EMPHYSEMA
Clinical trials for EMPHYSEMA explained in plain language.
Never miss a new study
Get alerted when new EMPHYSEMA trials appear
Sign up with your email to follow new studies for EMPHYSEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Three-Year quest to slow lung destruction in genetic emphysema
Disease control Not yet recruitingThis study aims to find the most effective dose of an existing medication (Respreeza/Zemaira) to slow the progression of lung damage in adults with emphysema caused by Alpha-1 antitrypsin deficiency. Over 270 participants will receive weekly intravenous infusions for three years …
Matched conditions: EMPHYSEMA
Phase: PHASE4 • Sponsor: CSL Behring • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New scan strategy aims to sharpen precision of lung valve therapy
Disease control Not yet recruitingThis study is testing if using a special type of scan (V/Q SPECT/CT) to pick which part of the lung to treat works better than the current standard method (CT scan and a pressure test) for people with severe emphysema. Participants will have valves placed in their lungs to help t…
Matched conditions: EMPHYSEMA
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New lung implant aims to help severe emphysema patients breathe
Disease control Not yet recruitingThis study is testing a new implantable device called an Artificial Bronchus to help adults with severe emphysema. The device is designed to reduce the amount of trapped air in the lungs, which could help patients breathe more easily and improve their quality of life. Researchers…
Matched conditions: EMPHYSEMA
Phase: NA • Sponsor: Pulmair Medical, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC